
|Videos|March 2, 2021
Dr. Michael Philip O'Leary on potential risks of penile implant surgery
Author(s)Urology Times staff
O’Leary discusses safety related to instillation of the Penuma penile enhancement implant.
Advertisement
Michael Philip O’Leary, MD, a professor of surgery at Harvard Medical School, discusses potential risks of surgical implantation Penuma, an FDA-cleared penile enhancement implant. O’Leary is 1 of 10 surgeons in the United States capable of performing this surgery, and he recently performed the first Penuma implant at Brigham and Women's Hospital, part of Harvard Medical School. Penuma is a permanent cosmetic penile implant customized to an individual patient’s anatomy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










